Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Methodology
Signal backtests
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Borie Dominique Christian — Cue Biopharma, Inc. insider: 2 transactions · InsiderLens

/ / Borie Dominique Christian

Borie Dominique Christian

See Remarks at Kyverna Therapeutics, Inc. · on record since Feb 7, 2024
Chief Medical Officer at Cue Biopharma, Inc. · on record since Jul 15, 2026
Head of Research & Development at Cue Biopharma, Inc. · on record since Jul 15, 2026

Insider trading activity of Borie Dominique Christian

Transactions on record: 2; since Jul 15, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 15, 2026

Figures computed from official regulatory filings — .

Companies where Borie Dominique Christian has traded

Cue Biopharma, Inc.2 tx · Jul 15, 2026

Track record of Borie Dominique Christian

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Borie Dominique Christian

Co-insiders of Borie Dominique Christian

Ahlers James MCue Biopharma, Inc.
Aktar MertKyverna Therapeutics, Inc.
Azam UsmanCue Biopharma, Inc.
Bain Capital Life Sciences Fund III, L.P.Kyverna Therapeutics, Inc.
Bain Capital Life Sciences III General Partner, LLCKyverna Therapeutics, Inc.
Bain Capital Life Sciences Investors, LLCKyverna Therapeutics, Inc.
Bain Capital Life Sciences Opportunities III GP, LLCKyverna Therapeutics, Inc.
Bain Capital Life Sciences Opportunities III, LPKyverna Therapeutics, Inc.
Baker Daniel G.Cue Biopharma, Inc.
Biddle Warner WestonKyverna Therapeutics, Inc.
Camardo Daniel A.Cue Biopharma, Inc.
Chaparro RodolfoCue Biopharma, Inc.
Chung James BumKyverna Therapeutics, Inc.
Church Jill MarieCue Biopharma, Inc.
CLARK IAN TKyverna Therapeutics, Inc.
Cohen Fred EKyverna Therapeutics, Inc.
Dac NadiaKyverna Therapeutics, Inc.
DIGIANDOMENICO ANTHONYCue Biopharma, Inc.
DRISCOLL FREDERICK WCue Biopharma, Inc.
Emany Sravan KumarKyverna Therapeutics, Inc.
Fletcher Aaron G.L.Cue Biopharma, Inc.
Fox Michael JCue Biopharma, Inc.
Garzone PamelaCue Biopharma, Inc.
GEHCHAN NAJIKyverna Therapeutics, Inc.
GILEAD SCIENCES INCKyverna Therapeutics, Inc.

This page republishes public regulatory disclosures.

GRASSO MARCKyverna Therapeutics, Inc.

Gray CameronCue Biopharma, Inc.

Harper Sean EKyverna Therapeutics, Inc.

HOWSON TAMAR DCue Biopharma, Inc.

Jones Ryan AlexanderKyverna Therapeutics, Inc.

Kiener Peter ACue Biopharma, Inc.

Kotzin Brian L.Kyverna Therapeutics, Inc.

Levisetti MatteoCue Biopharma, Inc.

Liapis Stephen ConstantineKyverna Therapeutics, Inc.

Lin Shao-LeeCue Biopharma, Inc.

Maag PeterKyverna Therapeutics, Inc.

Mancilla BethanyCue Biopharma, Inc.

MARLETT CHRISTOPHER ACue Biopharma, Inc.

Martini Gregory S.Kyverna Therapeutics, Inc.

MCKNIGHT STEVEN LCue Biopharma, Inc.

Meehan Viola MongCue Biopharma, Inc.

Meluzio Michael VincentCue Biopharma, Inc.

Millar Kerri-AnnCue Biopharma, Inc.

Miller Andrew CraigKyverna Therapeutics, Inc.

Morich FrankCue Biopharma, Inc.

NASSHORN PATRICIACue Biopharma, Inc.

Northpond Ventures III GP, LLCKyverna Therapeutics, Inc.

Northpond Ventures III, LPKyverna Therapeutics, Inc.

PASSERI DANIEL RCue Biopharma, Inc.

Pienta KennethCue Biopharma, Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src	Details
Cue Biopharma, Inc.	Jul 15, 2026	Award	31,500	0.00 USD	—	SEC
Cue Biopharma, Inc.	Jul 15, 2026	AwardD (derivative)	63,000	0.00 USD	—	SEC